Anghileri L J, Heidbreder M, Mathes R
Strahlentherapie. 1977 Jun;153(6):433-6.
The distribution of 125I-uracil and 125I-deoxyuridine in tumor-bearing animals has been studied. 125I-deoxyuridine shows the characteristics of a tumor-scanning agent. The metabolic incorporation by tumors of this DNA-precursor indicates a potential value of this radiocompound for their detection, differentiation and follow-up of their evolution after therapy.
对荷瘤动物体内125I-尿嘧啶和125I-脱氧尿苷的分布进行了研究。125I-脱氧尿苷显示出肿瘤扫描剂的特性。这种DNA前体被肿瘤代谢掺入表明该放射性化合物在肿瘤检测、鉴别及其治疗后演变的随访方面具有潜在价值。
